| Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 233 | 2020 |
| Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ... Frontiers in pharmacology 11, 108, 2020 | 138 | 2020 |
| Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications MM Nashilongo, B Singu, F Kalemeera, M Mubita, E Naikaku, A Baker, ... Cardiovascular drugs and therapy 31, 565-578, 2017 | 106 | 2017 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 104 | 2020 |
| Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications S Nakwatumbah, D Kibuule, B Godman, V Haakuria, F Kalemeera, ... Expert review of anti-infective therapy 15 (7), 713-721, 2017 | 90 | 2017 |
| Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ... Hospital practice 48 (2), 51-67, 2020 | 56 | 2020 |
| Initiatives across countries to reduce antibiotic utilisation and resistance patterns: impact and implications B Godman, J Fadare, D Kibuule, L Irawati, M Mubita, O Ogunleye, ... Drug resistance in bacteria, fungi, malaria, and cancer, 539-576, 2017 | 40 | 2017 |
| An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications D Kibuule, M Mubita, E Naikaku, F Kalemeera, BB Godman, E Sagwa International journal of clinical practice 71 (2), e12918, 2017 | 37 | 2017 |
| Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa A Massele, J Burger, NL Katende-Kyenda, F Kalemeera, T Kenaope, ... Expert review of pharmacoeconomics & outcomes research 15 (6), 885-888, 2015 | 26 | 2015 |
| Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia D Kibuule, P Aiases, N Ruswa, TW Rennie, RK Verbeeck, B Godman, ... ERJ open research 6 (1), 2020 | 19 | 2020 |
| Effect of changing from first-to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia F Kalemeera, C Mbango, M Mubita, E Naikaku, R Gaida, B Godman Expert review of anti-infective therapy 14 (8), 777-783, 2016 | 19 | 2016 |
| The potential effect of using the Cockcroft-Gault method on tenofovir-associated renal impairment reports and on clinical decisions regarding tenofovir use in individual … F Kalemeera, M Cockeran, M Mubita, D Kibuule, E Naikaku, A Massele, ... Journal of Infectious Diseases & Preventive Medicine 5 (3), 1000170, 2017 | 8 | 2017 |
| Piloting a new pharmacy internship support programme in Namibia T Rennie, N Coetzee, CJ Hunter, L Jonkman, F Kalemeera, D Kibuule, ... Pharmacy Education 18, 88-90, 2018 | 7 | 2018 |
| Drug resistance in bacteria, fungi, malaria, and cancer B Godman, J Fadare, D Kibuule, L Irawati, M Mubita, O Ogunleye, ... Springer, 2017 | 7 | 2017 |
| COVID-19 resilient pharmacy education: A grassroots work-integrated programme to strengthen the pharmaceutical workforce in Namibia D Mavu, J Lates, E Hango, T Rennie, M Lusepani, D Kibuule, M Mubita Pharmacy Education 20 (2), 205-11, 2020 | 5 | 2020 |
| Emergency compounding of COVID-19 medicines: A readiness programme to up-skill pharmacy graduates in Namibia D Mavu, M Mubita, Q Niaz, M Lusepani, S Nowaseb, T Enkara, ... Pharmacy Education 20 (2), 117-123, 2020 | 5 | 2020 |
| Ogunleye et al B Godman, J Fadare, D Kibuule, L Irawati, M Mubita Initiatives across countries to reduce antibiotic utilization and resistance …, 0 | 5 | |
| Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia BS Singu, M Mubita, MM Thikukutu, JK Mufenda, SB McKenzie, ... International Journal of Clinical Pharmacy 40, 520-525, 2018 | 4 | 2018 |
| Migration to online pharmacy education in Namibia: Successes, challenges and competence implications D Kibuule, J Lates, A Ishola, E Hango, F Kalemeera, M Knott, D Mavu, ... Pharmacy Education 20 (2), 174-182, 2020 | 3 | 2020 |
| Creating clinical pharmacy capacity in Namibia: a collaboration to establish a post-graduate pharmacy degree programme NL Corkhill, J Lates, M Mubita, D Kibuule, LJ Jonkman, D Hachey, ... International Journal of Clinical Pharmacy 42, 1528-1532, 2020 | 2 | 2020 |
